GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Coates, L. C. [1 ]
Ritchlin, C. T. [2 ]
Gossec, L. [3 ]
Helliwell, P. [4 ]
Rahman, P. [5 ]
Hsia, E. C. [6 ,7 ]
Kollmeier, A. [8 ]
Xu, X. L. [8 ]
Karyekar, C. [9 ]
Shawi, M. [9 ]
Noel, W. [10 ]
Jiang, Y. [11 ]
Sheng, S. [11 ]
Wang, Y. [11 ]
Mease, P. J. [12 ,13 ]
机构：
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[2] Univ Rochester, Med Ctr, Dept Med AllergyImmunol & Rheumatol, Rochester, NY 14642 USA
[3] Sorbonne Univ, Rheumatol, Paris, France
[4] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[5] Mem Univ Newfoundland, Craig L Dobbin Genet Res Ctr, St John, NF, Canada
[6] Janssen Res & Dev LLC, Immunol, Spring House, PA USA
[7] Univ Penn, Rheumatol, Philadelphia, PA 19104 USA
[8] Janssen Res & Dev LLC, Immunol, La Jolla, CA USA
[9] Janssen Res & Dev LLC, Immunol, Horsham, PA USA
[10] Janssen Res & Dev LLC, Immunol, Brussels, Belgium
[11] Janssen Res & Dev LLC, Biostat, Spring House, PA USA
[12] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[13] Univ Washington, Rheumatol Res, Seattle, WA 98195 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.167
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1024
引用
收藏
页码：781 / 782
页数：2
相关论文
共 50 条
  • [1] Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis
    Coates, Laura
    Ritchlin, Christopher
    Gossec, Laure
    Helliwell, Philip S.
    Rahman, Proton
    Hsia, Elizabeth
    Kollmeier, Alexa
    Xu, Xie
    Karyekar, Chetan
    Shawi, May
    Noel, Wim
    Jiang, Yusang
    Sheng, Shihong
    Wang, Yanli
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2774 - 2776
  • [2] GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Ranza, Roberto
    Coates, Laura C.
    Ritchlirn, Christopher T.
    Gossec, Laure
    Helliwell, Philip S.
    Rahman, Proton
    Hsia, Elizabeth C.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Karyekar, Chetan S.
    Shawi, May
    Noel, Wim
    Jiang, Yusang
    Sheng, Shihong
    Wang, Yanli
    Mease, Philip J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S101 - S101
  • [3] Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis
    Coates, Laura
    Ritchlin, Christopher
    Gossec, Laure
    Helliwell, Philip
    Rahman, Proton
    Hsia, Elizabeth
    Kollmeier, Alexa
    Xu, Xie
    Karyekar, Chetan
    Shawi, May
    Noel, Wim
    Jiang, Yusang
    Sheng, Shihong
    Agarwal, Prasheen
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis
    Coates, Laura C.
    Ritchlin, Christopher T.
    Gossec, Laure
    Helliwell, Philip S.
    Rahman, Proton
    Kollmeier, Alexa P.
    Xu, Xie L.
    Shawi, May
    Karyekar, Chetan S.
    Contre, Christine
    Noel, Wim
    Sheng, Shihong
    Wang, Yanli
    Xu, Stephen
    Mease, Philip J.
    RHEUMATOLOGY, 2023, 62 (02) : 606 - 616
  • [5] GUSELKUMAB PROVIDES DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE END-POINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Coates, L. C.
    Ritchlin, C. T.
    Gossec, L.
    Helliwell, P. S.
    Rahman, P.
    Hsia, E. C.
    Kollmeier, A. P.
    Xu, X. L.
    Karyekar, C.
    Shawi, M.
    Noel, W.
    Jiang, Y.
    Sheng, S.
    Agarwal, P.
    Mease, P. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1219 - 1220
  • [6] Efficacy of guselkumab using composite endpoints in patients with active psoriatic arthritis: Domain-specific efficacy from DISCOVER-1 and DISCOVER-2 phase 3 trials
    Coates, Laura C.
    Ritchlin, Christopher T.
    Gossec, Laure
    Helliwell, Philip S.
    Rahman, Proton
    Kollmeier, Alexa P.
    Karyekar, Chetan
    Sheng, Shihong
    Agarwal, Prasheen
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB127 - AB127
  • [7] EFFICACY OF GUSELKUMAB ON AXIAL-RELATED ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WITH IMAGING-CONFIRMED SACROILIITIS
    Mease, P.
    Helliwell, P.
    Gladman, D.
    Poddubnyy, D.
    Baraliakos, X.
    Chakravarty, S. D.
    Kollmeier, A. P.
    Hsia, E. C.
    Xu, L.
    Sheng, S.
    Shawi, M.
    Karyekar, C. S.
    Sweet, K.
    Deodhar, A.
    van der Heijde, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1220 - 1221
  • [8] EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OVER 56 WEEKS
    Boehncke, Wolf Henning
    Gottlieb, Alice
    Deodhar, Atul
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 48 - 49
  • [9] Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
    Curtis, Jeffrey
    McInne, Iain B.
    Rahman, Proton
    Gladman, Dafna
    Yang, Feifei
    Peterson, Steve
    Kollmeier, Alexa
    Shiff, Natalie
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1014 - 1016
  • [10] GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 2 YEARS OF DISCOVER-2
    Curtis, J.
    Mcinnes, I.
    Rahman, P.
    Gladman, D. D.
    Yang, F.
    Peterson, S.
    Kollmeier, A.
    Shiff, N.
    Han, C.
    Shawi, M.
    Tillett, W.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1568 - 1569
12345